Efficacy and Safety of Artemisinin-Based Antimalarials in Children with Malaria in Tanzania
Author Information
Author(s): Kabanywanyi Abdunoor M, Mwita Alex, Sumari Deborah, Mandike Renata, Mugittu Kefas, Abdulla Salim
Primary Institution: Ifakara Health Research and Development Centre, Tanzania
Hypothesis
The study aims to evaluate the efficacy and safety of artemisinin-based combination therapies (ACTs) compared to previous treatments for uncomplicated malaria in children.
Conclusion
The study found that artemether-lumefantrine (AL) is highly effective in treating uncomplicated malaria in children, supporting its use as the first-line treatment in Tanzania.
Supporting Evidence
- Both artemether-lumefantrine and artesunate plus amodiaquine were well tolerated by the children.
- The study showed a significant improvement in hemoglobin levels in both treatment groups.
- After PCR adjustments, the cure rates for artemether-lumefantrine reached 100%.
Takeaway
This study shows that a new malaria medicine works really well for kids, helping them get better quickly.
Methodology
An in vivo efficacy study was conducted with children aged 6–59 months who had uncomplicated malaria, comparing treatments over a 28-day follow-up.
Limitations
The study did not compare the two drugs directly and had a loss to follow-up of 18 patients.
Participant Demographics
Children aged 6–59 months with uncomplicated malaria.
Statistical Information
P-Value
< 0.001
Statistical Significance
p < 0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website